Paul von Autenried

Filings by Paul von Autenried span 2 companies, the busiest being Bristol Myers Squibb Co and Science 37 Holdings, Inc. We count 4 filings; the first trade dates from 30 July 2021 and the latest from 12 March 2024.

No open-market purchase appears, only 2 sales worth €2.4M. Other entries cover 1 option exercise.

Most recently, on 12 March 2024, the filings show a transaction worth €12k in Science 37 Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.